Skip to main content
. Author manuscript; available in PMC: 2020 May 3.
Published in final edited form as: J Proteome Res. 2019 Apr 1;18(5):2004–2011. doi: 10.1021/acs.jproteome.8b00774

Figure 3.

Figure 3.

Temporal profiles of the metabolites that differentiated carnitine-treated non-survivors and survivors (FDR <0.05). These included endogenous (A-M) and an exogenous metabolites (N). With the exception of (A) N-acetyl-L-phenylalanine and (F) phenylalanyltyrosine, all endogenous metabolites were higher in carnitine-treated non-survivors. Data are the median (IQR) of 7 male carnitine-treated survivors and 4 male carnitine-treated non-survivors at all time points except T48h (non-survivors, n=3).